Jagsonpal Pharmaceuticals
JAGSNPHARM · Pharma > Pharmaceuticals & Drugs · Chairman: R P S Kochhar · MD: R P S Kochhar · Listing date: Sept. 12, 1996 · New Delhi · http://www.jagsonpal.com

Stock Price vs Company Growth
1d
1.2%
1w
0.8%
1m
18.7%
3m
21.8%
6m
23.1%
1y
4.1%
5y
32.6%
10y
32.1%
all
21.1%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 236 1.2%
185
265
Company Overview

Sales
287 Cr
Growth: 7.9%
Profit after Tax
43.1 Cr
Growth: 5.3%
Small Cap
1,553 Cr
P/E: 37.6x
Industry P/E: 33.7x
Fundamentals

Sales (Cr) ₹ 287
Growth 7.9%
EBITDA 20.2%
P/S 5.4x
Dividend 1.0%
P/E 37.6x
Book Value ₹ 41.9
PEG Ratio 4.7x
ROE 16.2%
P/B 5.6x
Shareholding Pattern

Institutions
Promoters
Aresko Progressive Private Limited
65.71 %
Rajpal Singh Kochhar
4.63 %
Others
Investor Education And Protection Fund Authority
1.56 %
Sanjiv Kumar Dudeja
1.41 %
Lincoln P Coelho
1.16 %
Increase    Decrease    No change
Company Profile Detailed

In 1964 Jagsonpal started from humble beginnings with Jagmohan S. Kochhar operating a chemists shop in Delhi. Soon he expanded into making formulations. Mr. Kochhar’s vision was to spread health and healing in India on a larger scale. He was at the helm of the company from its inception, through the startup phase. Even though Jagsonpal was a small business at the time, his vision was to create one of India’s premiere pharmaceutical companies.
Investors (24)
Followers (1)